Our ambition

Pave the way for a truly personalized approach in cancer.

 

 

READ MORE

Translational biomarker approaches
to address patient needs

Pharmaco-imaging in support of therapeutic development

and for drug targeting.

 

 

READ MORE

State-of-the-art models for optimal
predictive value

Patient-derived xenografts and human immune system

models to allow better decisions.

 

 

READ MORE

Next generation kinase inhibitors
with unique properties

Potent and selective Nanocyclix leads for known

and novel kinases.

.

 

READ MORE

We partner to advance cancer
research

Joining forces to the benefits of patients.

February 8, 2013
Oncodesign generates "First-in-Class" opportunities for 6 kinases of high interest
READ MORE
World Pharma Congress, Philadelphia - June 4-6. Visit Taconic and Oncodesign at booth #12 at the upcoming WPC, and meet with Dr. Jean-François Mirjolet, Technology Director at Oncodesign.
READ MORE

ONCOLOGY TRANSLATIONAL

EXPERIMENTATION

A large panel of technological and scientific solutions for pharmacological qualification of your compounds : a unique oncology preclinical CRO

READ  MORE

DISCOVERY PARTNERING

 

A platform-based approach for the discovery of novel chemical entities with therapeutic and diagnostic potential

READ  MORE